BNP Paribas Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

BNP Paribas Asset Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,924	Closed	-$332K	–	1115
2015 Q1	$332K	Buy	+1,924	New	+$282K	﹤0.01%	968
2014 Q4	–	Sell	-38,686	Closed	-$6.04M	–	1010
2014 Q3	$6.04M	Buy	38,686 +16,313	+73%	+$2.36M	0.05%	386
2014 Q2	$2.76M	Sell	22,373 -5,290	-19%	-$585K	0.02%	578
2014 Q1	$2.87M	Buy	+27,663	New	+$2.83M	0.02%	559

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

BNP Paribas Asset Management's SLXP Position: Q2 2015 in Review

BNP Paribas Asset Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,924 shares — an estimated $332K sold.

BNP Paribas Asset Management first reported a position in SLXP in Q1 2014 and held it in 4 quarters. The position peaked at $6.04M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

BNP Paribas Asset Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
BNP Paribas Asset Management sold 1,924 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $332K.
BNP Paribas Asset Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2014 and held it in 4 quarters.
BNP Paribas Asset Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $6.04M in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on BNP Paribas Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.